Last reviewed · How we verify
Probiotic (Inersan)
Inersan is a probiotic formulation that restores beneficial gut microbiota to improve intestinal health and immune function.
Inersan is a probiotic formulation that restores beneficial gut microbiota to improve intestinal health and immune function. Used for Gastrointestinal disorders associated with dysbiosis, Immune support and gut health maintenance.
At a glance
| Generic name | Probiotic (Inersan) |
|---|---|
| Also known as | Inersan contains not less than 1 billion CFU of Lactobacillus brevis CD2 |
| Sponsor | CD Pharma India Pvt. Ltd. |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
Probiotics work by introducing live beneficial bacteria into the gastrointestinal tract, where they colonize the gut microbiome, compete with pathogenic organisms, produce short-chain fatty acids, and strengthen the intestinal barrier. This restoration of eubiotic balance enhances local and systemic immune responses and may reduce inflammation and improve digestive function.
Approved indications
- Gastrointestinal disorders associated with dysbiosis
- Immune support and gut health maintenance
Common side effects
- Mild gastrointestinal symptoms (bloating, gas)
- Transient digestive discomfort
Key clinical trials
- Effect of Probiotic Lozenge on Gingivitis and Periodontitis (PHASE3)
- Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients. (PHASE3)
- Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection (NA)
- Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis (PHASE3)
- Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Probiotic (Inersan) CI brief — competitive landscape report
- Probiotic (Inersan) updates RSS · CI watch RSS
- CD Pharma India Pvt. Ltd. portfolio CI